摘要
目的探讨单唾液酸四已糖神经节苷酯注射液治疗急性脑梗死的疗效。方法随机选出152例急性脑梗死患者分为两组,治疗组用单唾液酸四已糖神经节苷酯注射液40mg加入NS250ml静脉滴注,1次/d,21d为1个疗程。对照组用胞二磷胆碱注射液0.75加入NS250ml静脉滴注,疗程及用法同治疗组。结果采用治疗组基本治愈率(30.5%)、总有效率(84.2%),明显高于对照组基本治愈率(18.6%)、总有效率(65.6%),两者有统计学差异(P<0.05)。结论早期应用单唾液酸四已糖神经节苷酯注射液治疗急性脑梗死,可加速神经功能的恢复,提高患者的生存质量,改善预后。
Objective To evaluate the curative effect of GM-1 injection on acute cerebral infarction. Methods Total 152 patients with acute cerebral infarction were randomly divided into two group：the treatment group and control group. The treatment group were treated with GM-1 （40 nag per day for 21 days） and the control group were treated with citicoline （0.75 per day for 21 day）. Results There was significant difference in the total effective rate between the treatment group （84. 2% ） and the control group （65.6%） （P 〈 0. 05 ）. Conclusion The patients with acute cerebral infarction during the early period should be treated with GM-1, which will speed the recovery of neurological function and improve the quality of life.
出处
《中国实用医药》
2009年第35期18-19,共2页
China Practical Medicine
